国际妇产科学杂志2024,Vol.51Issue(4) :384-387.DOI:10.12280/gjfckx.20240004

卵巢成熟性囊性畸胎瘤恶性转化一例

Malignant Transformation of Mature Cystic Teratoma of Ovary:A Case Report

季安璇 赵淑华
国际妇产科学杂志2024,Vol.51Issue(4) :384-387.DOI:10.12280/gjfckx.20240004

卵巢成熟性囊性畸胎瘤恶性转化一例

Malignant Transformation of Mature Cystic Teratoma of Ovary:A Case Report

季安璇 1赵淑华1
扫码查看

作者信息

  • 1. 130000 长春,吉林大学第二医院妇产科
  • 折叠

摘要

卵巢成熟性囊性畸胎瘤(mature cystic teratoma of ovary,MCTO)是最常见的卵巢生殖细胞肿瘤,通常为良性,然而在极少数情况下,其可能发生恶性转化(malignant transformation,MT).MT-MCTO多见于绝经后期女性,由于其罕见性,目前尚缺乏标准的诊治方案.报告1例77岁MT-MCTO为鳞状细胞癌Ⅱ B期患者的诊治过程,该患者在经肿瘤细胞减灭术后接受1个疗程博来霉素+依托泊苷+顺铂方案化疗.然而,由于患者身体情况无法耐受进一步治疗,随访术后半年死亡.

Abstract

Mature cystic teratoma of ovary(MCTO)is the most common ovarian germ cell tumor,which is usually benign.However,in rare cases,it may undergo malignant transformation.Malignant transformation of MCTO(MT-MCTO)is common in postmenopausal women.Due to its rarity,there is still no standard diagnosis and therapeutic options.This paper reports the diagnosis and treatment of a 77-year-old patient with MT-MCTO to squamous cell carcinoma at stage Ⅱ B.After cytoreductive surgery,the patient received a course of chemotherapy with bleomycin+etoposide+cisplatin.However,because the patient's physical condition could not tolerate further treatment,the patient died after six months of postoperative follow-up.

关键词

畸胎瘤/卵巢肿瘤/癌,鳞状细胞/治疗/预后

Key words

Teratoma/Ovarian neoplasms/Carcinoma,squamous cell/Therapy/Prognosis

引用本文复制引用

出版年

2024
国际妇产科学杂志
天津市医学科学技术信息研究所

国际妇产科学杂志

CSTPCD
影响因子:1.155
ISSN:1674-1870
段落导航相关论文